Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Search by expertise, name or affiliation
Hypertension and cardiovascular disease
C. P. Mouton
, N. L. Lasser
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hypertension and cardiovascular disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hypertension
100%
Hypertension and Cardiovascular Disease
100%
Beta-blockers
60%
Risk Factors
40%
White People
40%
Clinical Trials
40%
Non-pharmaceutical Interventions
40%
Diuretics
40%
Patient Characteristics
20%
Initial Treatment
20%
Blood Pressure
20%
Obesity
20%
Susceptible Individuals
20%
Number of Factors
20%
Women's Groups
20%
Ethnic Groups
20%
Drug Treatment
20%
Primary Prevention
20%
Pharmacological Therapy
20%
Disease Conditions
20%
Weight Reduction
20%
Follow-up Monitoring
20%
Overtreatment
20%
High Blood Pressure
20%
Hypertension Management
20%
Antihypertensive Drugs
20%
Lowest Effective Dose
20%
White Male
20%
New Classification
20%
African American Men
20%
Lifestyle Modification
20%
Four-stage
20%
Calcium Channel Antagonist
20%
Stage-based
20%
ACE Inhibitors
20%
Dietary Sodium Restriction
20%
High Salt Intake
20%
Family History of Hypertension
20%
Medicine and Dentistry
Beta Adrenergic Receptor Blocking Agent
100%
Cardiovascular Disease
100%
Drug Therapy
100%
Clinical Trial
66%
Apoplexy
66%
Blood Pressure
66%
Diuretic Agent
66%
Patient Characteristics
33%
Disease
33%
ACE Inhibitor
33%
Calcium Channel Blocking Agent
33%
Primary Prevention
33%
Ethnic Group
33%
High Sodium Intake
33%
Family History
33%
Sodium Intake
33%
Antihypertensive Agent
33%
Lifestyle Modification
33%
Nursing and Health Professions
Beta Adrenergic Receptor Blocking Agent
100%
Drug Therapy
100%
Cardiovascular Disease
100%
Blood Pressure
66%
Diuretic Agent
66%
Disease
33%
Practice Guideline
33%
Ethnic Group
33%
Primary Prevention
33%
Sodium Intake
33%
Family History
33%
Antihypertensive Agent
33%
Lifestyle Modification
33%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Calcium Channel Blocking Agent
33%
High Sodium Intake
33%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Adrenergic Receptor Blocking Agent
100%
Cardiovascular Disease
100%
Clinical Trial
66%
Pharmacotherapy
66%
Diuretic Agent
66%
Disease
33%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Calcium Channel Blocker
33%
Antihypertensive Agent
33%